TEMTempus AI, Inc.

Nasdaq www.tempus.com


$ 67.48 $ 5.99 (9.74 %)    

Wednesday, 21-Aug-2024 12:59:02 EDT
QQQ $ 481.82 $ 0.70 (0.15 %)
DIA $ 408.78 $ -0.45 (-0.11 %)
SPY $ 560.09 $ 0.16 (0.03 %)
TLT $ 98.82 $ 0.14 (0.14 %)
GLD $ 231.71 $ 0.05 (0.02 %)
$ 58.71
$ 61.49
$ 67.30 x 100
$ 67.60 x 100
$ 61.13 - $ 67.48
$ 22.89 - $ 74.83
3,133,817
na
9.06B
$ -2.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ast-spacemobile-and-rocket-lab-are-among-top-7-best-performing-mid-cap-stocks-last-week-aug-11-aug-17-are-the-others-in-your-portfolio

Seven mid-cap stocks soared last week, including ASTS, TEM, INTA, LOAR, RKLB, QFIN, and LITE. Have you added them to your portf...

 tempus-ai-soars-to-new-highs-investments-from-google-and-softbank-boost-bullish-sentiment

Tempus AI stock is at all-time high of $47.81, up 17.27% since IPO in June. SoftBank invested $189 million in the company.

Core News & Articles

Tempus invests $36 million by exercising warrants and purchasing additional sharesPersonalis, Inc. (NASDAQ:PSNL) and Tempus AI,...

Core News & Articles

Piper Sandler analyst David Westenberg initiates coverage on Tempus AI (NASDAQ:TEM) with a Neutral rating and announces Pric...

Core News & Articles

Piper Sandler analyst David Westenberg initiates coverage on Tempus AI (NASDAQ:TEM) with a Neutral rating and announces Pric...

Core News & Articles

JP Morgan analyst Rachel Vatnsdal maintains Tempus AI (NASDAQ:TEM) with a Overweight and raises the price target from $42 to...

Core News & Articles

Needham analyst Ryan MacDonald reiterates Tempus AI (NASDAQ:TEM) with a Buy and maintains $47 price target.

Core News & Articles

Tempus AI (NASDAQ:TEM) reported quarterly sales of $165.969 million which beat the analyst consensus estimate of $145.807 milli...

Core News & Articles

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, announced an expanded collaboration w...

 riot-platforms--north-face-parent-vf-corp-are-among-11-mid-cap-stocks-that-performed-the-best-last-week-july-14-july-20-are-others-in-your-portfolio

Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%...

Core News & Articles

Available Today for Life Science Research Use OnlyTempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precisi...

 investor-that-backed-moderna-raises-36b-for-ai-driven-biotech-ventures

The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelli...

Core News & Articles

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, has reached a research milestone of o...

 tempus-ai-has-massive-market-opportunity-for-this-healthcare-technology-bullish-analyst-says

William Blair initiated coverage on Tempus AI, highlighting its unique approach and business model in healthcare technology. Th...

Core News & Articles

B of A Securities analyst Michael Ryskin initiates coverage on Tempus AI (NASDAQ:TEM) with a Buy rating and announces Price ...

 tempus-could-gain-share-in-ai-health-care-market-poised-to-grow-by-over-30

Tempus AI provides advanced technology to the healthcare and diagnostics market, which is expected to grow at +30%.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION